Literature DB >> 19879804

T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?

Stanley H Appel1, David R Beers, Jenny S Henkel.   

Abstract

Neuroinflammation is a pathological hallmark in Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), and is characterized by activated microglia and infiltrating T cells at sites of neuronal injury. In PD and ALS, neurons do not die alone; neuronal injury is non-cell-autonomous and depends on a well-orchestrated dialogue in which neuronally secreted misfolded proteins activate microglia and initiate a self-propagating cycle of neurotoxicity. Diverse populations and phenotypes of CD4(+) T cells crosstalk with microglia, and depending on their activation status, influence this dialogue and promote neuroprotection or neurotoxicity. A greater understanding of the T cell population that mediates these effects, as well as the molecular signals involved should provide targets for neuroprotective immunomodulation to treat these devastating neurodegenerative diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19879804      PMCID: PMC4126423          DOI: 10.1016/j.it.2009.09.003

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  93 in total

1.  Early activation of microglia as antigen-presenting cells correlates with T cell-mediated protection and repair of the injured central nervous system.

Authors:  Iftach Shaked; Ziv Porat; Roman Gersner; Jonathan Kipnis; Michal Schwartz
Journal:  J Neuroimmunol       Date:  2004-01       Impact factor: 3.478

2.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Du-Chu Wu; Peter Teismann; Kim Tieu; Miquel Vila; Vernice Jackson-Lewis; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

3.  Vulnerability of human neurons to T cell-mediated cytotoxicity.

Authors:  Fabrizio Giuliani; Cynthia G Goodyer; Jack P Antel; V Wee Yong
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

Review 4.  Neuronal regulation of immune responses in the central nervous system.

Authors:  Li Tian; Heikki Rauvala; Carl G Gahmberg
Journal:  Trends Immunol       Date:  2009-01-12       Impact factor: 16.687

5.  FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

Authors:  S Hunot; N Dugas; B Faucheux; A Hartmann; M Tardieu; P Debré; Y Agid; B Dugas; E C Hirsch
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

6.  Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system.

Authors:  Jonathan Kipnis; Tal Mizrahi; Ehud Hauben; Iftach Shaked; Ethan Shevach; Michal Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-12       Impact factor: 11.205

7.  MPTP, MPP+ and mitochondrial function.

Authors:  W J Nicklas; S K Youngster; M V Kindt; R E Heikkila
Journal:  Life Sci       Date:  1987-02-23       Impact factor: 5.037

8.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation.

Authors:  Hania Kebir; Katharina Kreymborg; Igal Ifergan; Aurore Dodelet-Devillers; Romain Cayrol; Monique Bernard; Fabrizio Giuliani; Nathalie Arbour; Burkhard Becher; Alexandre Prat
Journal:  Nat Med       Date:  2007-09-09       Impact factor: 53.440

9.  Expression of the histocompatibility glycoprotein HLA-DR in neurological disease.

Authors:  P L McGeer; S Itagaki; E G McGeer
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

10.  alpha-Synuclein and neuronal cell death.

Authors:  Mark R Cookson
Journal:  Mol Neurodegener       Date:  2009-02-04       Impact factor: 14.195

View more
  109 in total

Review 1.  Neuroinflammation in Huntington's disease.

Authors:  Thomas Möller
Journal:  J Neural Transm (Vienna)       Date:  2010-06-10       Impact factor: 3.575

2.  Peripheral nerve inflammation in ALS mice: cause or consequence.

Authors:  Osamu Kano; David R Beers; Jenny S Henkel; Stanley H Appel
Journal:  Neurology       Date:  2012-02-29       Impact factor: 9.910

3.  Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.

Authors:  Bing Liao; Weihua Zhao; David R Beers; Jenny S Henkel; Stanley H Appel
Journal:  Exp Neurol       Date:  2012-06-23       Impact factor: 5.330

4.  Inflammation in neuroviral diseases.

Authors:  Pascale Giraudon; Arlette Bernard
Journal:  J Neural Transm (Vienna)       Date:  2010-08       Impact factor: 3.575

Review 5.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

6.  Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice.

Authors:  David R Beers; Weihua Zhao; Bing Liao; Osamu Kano; Jinghong Wang; Ailing Huang; Stanley H Appel; Jenny S Henkel
Journal:  Brain Behav Immun       Date:  2010-12-19       Impact factor: 7.217

7.  Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice.

Authors:  Haeman Jang; David Boltz; Jennifer McClaren; Amar K Pani; Michelle Smeyne; Ane Korff; Robert Webster; Richard Jay Smeyne
Journal:  J Neurosci       Date:  2012-02-01       Impact factor: 6.167

8.  Delayed caffeine treatment prevents nigral dopamine neuron loss in a progressive rat model of Parkinson's disease.

Authors:  Patricia K Sonsalla; Lai-Yoong Wong; Suzan L Harris; Jason R Richardson; Ida Khobahy; Wenhao Li; Bharathi S Gadad; Dwight C German
Journal:  Exp Neurol       Date:  2012-01-28       Impact factor: 5.330

9.  Immunological aspects in amyotrophic lateral sclerosis.

Authors:  Maria Carolina O Rodrigues; Júlio C Voltarelli; Paul R Sanberg; Cesario V Borlongan; Svitlana Garbuzova-Davis
Journal:  Transl Stroke Res       Date:  2012-05-03       Impact factor: 6.829

Review 10.  The role of glutamate and the immune system in organophosphate-induced CNS damage.

Authors:  Arik Eisenkraft; Avshalom Falk; Arseny Finkelstein
Journal:  Neurotox Res       Date:  2013-03-27       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.